Ctt Pharmaceutical Holdings annual operating cash flow
2010
2011
2012
2013
2014
2024
2025
Ctt Pharmaceutical Holdings Operating Cash Flow Growth & History (CTTH)
Ctt Pharmaceutical Holdings's operating cash flow was −$75,467 for fiscal 2025.
View full Ctt Pharmaceutical Holdings company overviewCtt Pharmaceutical Holdings annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$75,467 | $152,853 | — |
| 2024 | 2024-12-31 | −$228,320 | — | — |
| 2014 | 2014-12-31 | −$72,250 | $63,979 | — |
| 2013 | 2013-12-31 | −$136,229 | $890,782 | — |
| 2012 | 2012-12-31 | −$1.0M | −$710,879 | — |
| 2011 | 2011-12-31 | −$316,132 | $1.4M | — |
| 2010 | 2010-12-31 | −$1.7M | — | — |
Ctt Pharmaceutical Holdings quarterly operating cash flow
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating cash flow | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$7,058 | $9,121 | — |
| Q1 2026 | 2026-03-31 | −$19,071 | $12,533 | — |
| Q4 2025 | 2025-12-31 | −$15,279 | — | — |
| Q3 2025 | 2025-09-30 | −$12,405 | — | — |
| Q2 2025 | 2025-06-30 | −$16,179 | — | — |
| Q1 2025 | 2025-03-31 | −$31,604 | — | — |
| Q3 2015 | 2015-09-30 | −$15,527 | $8,680 | — |
| Q2 2015 | 2015-06-30 | −$29,158 | −$421 | — |
| Q1 2015 | 2015-03-31 | −$39,652 | −$39,322 | — |
| Q4 2014 | 2014-12-31 | −$18,976 | −$14,671 | — |
| Q3 2014 | 2014-09-30 | −$24,207 | $176 | — |
| Q2 2014 | 2014-06-30 | −$28,737 | $5,134 | — |
| Q1 2014 | 2014-03-31 | −$330 | $73,340 | — |
| Q4 2013 | 2013-12-31 | −$4,305 | $85,114 | — |
| Q3 2013 | 2013-09-30 | −$24,383 | $132,201 | — |
| Q2 2013 | 2013-06-30 | −$33,871 | $227,636 | — |
| Q1 2013 | 2013-03-31 | −$73,670 | $445,831 | — |
| Q4 2012 | 2012-12-31 | −$89,419 | $520,796 | — |
| Q3 2012 | 2012-09-30 | −$156,584 | $4,146 | — |
| Q2 2012 | 2012-06-30 | −$261,507 | −$727,840 | — |
| Q1 2012 | 2012-03-31 | −$519,501 | −$507,981 | — |
| Q4 2011 | 2011-12-31 | −$610,215 | — | — |
| Q3 2011 | 2011-09-30 | −$160,730 | $868,585 | — |
| Q2 2011 | 2011-06-30 | $466,333 | $755,882 | — |
| Q1 2011 | 2011-03-31 | −$11,520 | — | — |
| Q3 2010 | 2010-09-30 | −$1.0M | — | — |
| Q2 2010 | 2010-06-30 | −$289,549 | — | — |
Ctt Pharmaceutical Holdings operating cash flow trends
Between the periods ended 2010-12-31 and 2025-12-31, Ctt Pharmaceutical Holdings's operating cash flow increased from −$1.7M to −$75,467, a change of $1.6M. The latest reported quarter, Q2 2026, shows −$7,058.
About the metric
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
Calculation and source
SEC-reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ctt Pharmaceutical Holdings source filings ↗